Lipfendra Cholesterol Pill: What You Need to Know

If your cholesterol is still high even after eating well and taking a statin, you are not alone. For years, the next step meant giving yourself a shot at home. But that just changed. The FDA just approved Lipfendra (enlicitide), the first-ever daily pill that works like those injectable drugs. Here is everything you need to know about the Lipfendra cholesterol pill — how it works, who it is for, what it costs, and the one big caveat you should know before you ask your doctor about it.

What Is the Lipfendra Cholesterol Pill?

On July 16, 2026, the FDA approved Lipfendra (enlicitide) for adults with high LDL cholesterol. It belongs to a class of drugs called PCSK9 inhibitors. These drugs are very good at lowering “bad” cholesterol. But until now, every PCSK9 inhibitor came as a shot.

Lipfendra is a pill. That is a big deal for the millions of people who need stronger cholesterol treatment but do not want to deal with needles. “Being able to have an oral version of this medication is really important,” said Yu-Ming Ni, MD, a cardiologist at MemorialCare Heart and Vascular Institute. “I have a lot of people who are hesitant to even start because they don’t want to give themselves injections.”

Here is the thing. Statins work by reducing how much cholesterol your liver makes. Lipfendra works differently. It helps your liver pull more cholesterol out of your blood. Because they target two different pathways, you can take them together. That is exactly what the clinical trials tested — people already on the highest statin dose they could handle.

How Well Does the Lipfendra Cholesterol Pill Work?

Pretty impressively, actually. The approval is based on two large phase 3 trials involving more than 3,200 adults. Both were published in top medical journals.

In the main trial, called CORALreef Lipids, people taking Lipfendra saw their LDL cholesterol drop by about 56% compared to those on a placebo. The results were published in the New England Journal of Medicine. In a second trial focused on people with an inherited form of high cholesterol (HeFH), the reduction was about 59%, according to a study in JAMA. A third trial in JACC showed Lipfendra outperformed other oral options like ezetimibe and bempedoic acid by a wide margin.

But here is the honest truth. These trials measured how much Lipfendra lowers cholesterol. They did not measure whether it prevents heart attacks and strokes. That study — called CORALreef Outcomes — is still running. It has enrolled more than 14,500 people. We do not have those results yet.

Now, the FDA accepts LDL reduction as a valid stand-in for lower heart risk. And decades of research show that lower cholesterol means lower risk. But Lipfendra itself has not been proven to prevent heart attacks the way Repatha has. Most experts expect it will, given how the drug class works. But the data is not in yet.

Who Should Ask Their Doctor About Lipfendra?

You might be a candidate if your LDL cholesterol is still above your target range despite being on a statin. The updated 2026 ACC/AHA cholesterol guidelines set aggressive targets:

• Borderline or intermediate risk: LDL below 100 mg/dL
• High risk: LDL below 70 mg/dL
• Very high risk or existing heart disease: LDL below 55 mg/dL

Many people cannot reach these targets with statins alone. “We are targeting numbers less than 55 milligrams per deciliter per the new cholesterol guidelines,” said Anurag Mehta, MD, a preventive cardiologist at Emory Healthcare. “And in those circumstances, the statin medications many times — even at the highest tolerable dose — are not enough.”

Lipfendra is also approved for people with heterozygous familial hypercholesterolemia (HeFH). This is an inherited condition that causes very high LDL from birth. If you have a family history of early heart disease or very high cholesterol, this might apply to you.

How to Take Lipfendra: Practical Details

This matters more than you might think. Lipfendra has specific instructions that affect how well it works.

• Take it in the morning on an empty stomach with water, black coffee, or plain tea.
• Swallow the tablet whole. Do not crush, split, or chew it.
• Wait at least 30 minutes before you eat or drink anything else.
• Store it at room temperature in the original bottle with the desiccant (that little packet that keeps it dry).

If you miss a dose, take it as soon as you remember. But if it is almost time for your next dose, skip the missed one. Do not double up.

Side Effects and Safety

The safety profile is reassuring. In the main trial, side effects occurred about as often as with a placebo. In the HeFH trial, the most common side effects were diarrhea (7% vs 2% with placebo) and dizziness (9% vs 4%). A systematic review in Endocrine Practice confirmed that oral PCSK9 inhibitors are generally well-tolerated, though diarrhea is slightly more common.

One advantage over injectable PCSK9 inhibitors: no injection site reactions. No bruising, no swelling, no redness at the injection spot. For some people, that alone makes the pill worth considering.

What Does Lipfendra Cost?

The list price is $10.50 per day, or about $315 for a 30-day supply, according to Merck, the manufacturer. But here is the thing. Most people will not pay that full amount.

Merck says most patients, including those on Medicare, will pay less out of pocket. The company plans a coupon program for people with commercial insurance and a direct-to-patient option for eligible patients. How much you actually pay will depend heavily on your insurance plan.

For context, injectable PCSK9 inhibitors like Repatha and Praluent typically cost $500-$600 per month before insurance. So Lipfendra is priced at about half that. Still not cheap. But more accessible than the shots.

Lipfendra vs Other Cholesterol Treatments

Here is how the Lipfendra cholesterol pill stacks up against other options:

• Statins: Lower LDL by 35-50%. Reduce heart attack risk. First-line therapy. Generic and affordable.
• Ezetimibe (Zetia): Lowers LDL by 15-20%. Pill form. Often added to statins.
• Bempedoic acid (Nexletol): Lowers LDL by up to 28%. Pill form. For people who cannot take statins.
• Injectable PCSK9 inhibitors (Repatha, Praluent): Lower LDL by 50-60%. Proven to reduce heart attacks and strokes. Shots every 2 weeks or twice a year.
• Lipfendra (enlicitide): Lowers LDL by 56-60%. First oral PCSK9 inhibitor. No injection needed. Heart attack prevention data still pending.

The choice comes down to what works for you. “What does the patient want?” Mehta said. “Are they comfortable with giving themselves an injection every two weeks? Do they want to come to the office and get a shot twice a year? Or do they just want to take a pill?”

Lifestyle Still Comes First

Both cardiologists interviewed for this article agreed on one thing. Medication is not a replacement for healthy habits. “The biggest impact on cholesterol levels is diet,” Ni said.

A Mediterranean-style diet — rich in vegetables, fruits, whole grains, fish, and healthy fats — remains the foundation. So does regular exercise. Mehta recommends at least 150 minutes of aerobic activity per week plus strength training.

Think of Lipfendra as a tool in your heart health toolkit. It is there for when lifestyle and statins are not enough to get you to those new, more aggressive LDL targets. It is not a shortcut around good habits.

The Bottom Line

The Lipfendra cholesterol pill is a real step forward. For the first time, people who need PCSK9 inhibitor-level cholesterol lowering have a daily pill option instead of a shot. That matters for the millions of women who avoid injectable treatments or whose statin alone is not enough.

But here is what I want you to remember. Lipfendra lowers cholesterol powerfully — about 56 to 60 percent. It is well-tolerated. It costs about $315 a month before insurance. And it works alongside your statin, not instead of it.

The one honest caveat: we are still waiting for the long-term study to confirm that Lipfendra prevents heart attacks and strokes. The science strongly suggests it will. But the data is not in yet. That is not a reason to avoid it. It is just a reason to have an informed conversation with your doctor.

If your cholesterol is still too high despite your best efforts with diet, exercise, and statins, ask your doctor about Lipfendra. It might be the missing piece you have been waiting for.